lauric acid has been researched along with alprostadil in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Irie, T; Manako, T; Saita, M; Uekama, K; Yano, T | 1 |
| Aoyama, T; Funae, Y; Gelboin, HV; Gonzalez, FJ; Hardwick, JP; Imaoka, S | 1 |
| Aihara, H; Araki, H; Goto, J; Otomo, S | 1 |
| Dohi, M; Motoyama, Y; Sakata, Y; Seki, J; Yoshida, K | 1 |
| Gonzalez, FJ; Imaoka, S; Kim, HY; Kimura, S; Ogawa, H; Wedlund, PJ | 1 |
5 other study(ies) available for lauric acid and alprostadil
| Article | Year |
|---|---|
Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101.
Topics: Administration, Topical; Alprostadil; Animals; Cyclodextrins; Drug Carriers; Drug Combinations; Ear; Lauric Acids; Male; Ointments; Peripheral Vascular Diseases; Pyrroles; Rabbits | 1992 |
Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the omega- and (omega-1)-hydroxylation of fatty acids and the omega-hydroxylation of prostaglandins E1 and F2 alpha.
Topics: Alprostadil; Animals; Blotting, Western; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dinoprost; Electrophoresis, Polyacrylamide Gel; Fatty Acids; Gene Expression; Humans; Hydroxylation; Lauric Acids; Liver; Mixed Function Oxygenases; Palmitic Acid; Palmitic Acids; Rats; Sequence Homology, Nucleic Acid; Vaccinia virus | 1990 |
A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
Topics: Alprostadil; Animals; Arterial Occlusive Diseases; Dosage Forms; Lauric Acids; Male; Microspheres; Prostaglandins A; Rats; Rats, Inbred Strains | 1986 |
Effect of TFC-612, a 7-thia prostaglandin E1 derivative, on a peripheral arterial occlusive disease model in rats.
Topics: Alprostadil; Animals; Arterial Occlusive Diseases; Blood Pressure; Disease Models, Animal; Lauric Acids; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Skin | 1995 |
Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.
Topics: Alprostadil; Amino Acid Sequence; Animals; Arachidonic Acid; Base Sequence; Cloning, Molecular; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; DNA Probes; DNA, Complementary; Gene Expression; Kidney; Lauric Acids; Molecular Sequence Data; Oxygenases; Rats; Spectrophotometry | 1993 |